Huger FP - Search Results

1

Aminopyridine carbamic acid esters: synthesis and potential as acetylcholinesterase inhibitors and acetylcholine releasers.

Shutske GM, Tomer JD, Kapples KJ, Hrib NJ, Jurcak JG, Bores GM, Huger FP, Petko W, Smith CP. Shutske GM, et al. Among authors: huger fp. J Pharm Sci. 1992 Apr;81(4):380-5. doi: 10.1002/jps.2600810419. J Pharm Sci. 1992. PMID: 1501077

2

9-Amino-1,2,3,4-tetrahydroacridin-1-ols: synthesis and evaluation as potential Alzheimer's disease therapeutics.

Shutske GM, Pierrat FA, Kapples KJ, Cornfeldt ML, Szewczak MR, Huger FP, Bores GM, Haroutunian V, Davis KL. Shutske GM, et al. Among authors: huger fp. J Med Chem. 1989 Aug;32(8):1805-13. doi: 10.1021/jm00128a024. J Med Chem. 1989. PMID: 2754707

3

Synthesis and biological evaluation of a series of substituted N-alkoxyimides and -amides as potential atypical antipsychotic agents.

Hrib NJ, Jurcak JG, Huger FP, Errico CL, Dunn RW. Hrib NJ, et al. Among authors: huger fp. J Med Chem. 1991 Mar;34(3):1068-72. doi: 10.1021/jm00107a028. J Med Chem. 1991. PMID: 1672156

4

(+/-)-9-Amino-1,2,3,4-tetrahydroacridin-1-ol. A potential Alzheimer's disease therapeutic of low toxicity.

Shutske GM, Pierrat FA, Cornfeldt ML, Szewczak MR, Huger FP, Bores GM, Haroutunian V, Davis KL. Shutske GM, et al. Among authors: huger fp. J Med Chem. 1988 Jul;31(7):1278-9. doi: 10.1021/jm00402a002. J Med Chem. 1988. PMID: 3385720 No abstract available.

5

Synthesis and evaluation of 5-amino-5,6,7,8-tetrahydroquinolinones as potential agents for the treatment of Alzheimer's disease.

Fink DM, Bores GM, Effland RC, Huger FP, Kurys BE, Rush DK, Selk DE. Fink DM, et al. Among authors: huger fp. J Med Chem. 1995 Sep 1;38(18):3645-51. doi: 10.1021/jm00018a025. J Med Chem. 1995. PMID: 7658452

6

HP 749 enhances calcium-independent release of [3H]norepinephrine from rat cortical slices and synaptosomes.

Smith CP, Huger FP, Petko W, Kongsamut S. Smith CP, et al. Among authors: huger fp. Neurochem Res. 1994 Oct;19(10):1265-70. doi: 10.1007/BF01006816. Neurochem Res. 1994. PMID: 7891842

7

Synthesis and structure-activity relationships of N-propyl-N-(4-pyridinyl)-1H-indol-1-amine (besipirdine) and related analogs as potential therapeutic agents for Alzheimer's disease.

Klein JT, Davis L, Olsen GE, Wong GS, Huger FP, Smith CP, Petko WW, Cornfeldt M, Wilker JC, Blitzer RD, Landau E, Haroutunian V, Martin LL, Effland RC. Klein JT, et al. Among authors: huger fp. J Med Chem. 1996 Jan 19;39(2):570-81. doi: 10.1021/jm9506433. J Med Chem. 1996. PMID: 8558529

8

Substituted (pyrroloamino)pyridines: potential agents for the treatment of Alzheimer's disease.

Davis L, Olsen GE, Klein JT, Kapples KJ, Huger FP, Smith CP, Petko WW, Cornfeldt M, Effland RC. Davis L, et al. Among authors: huger fp. J Med Chem. 1996 Jan 19;39(2):582-7. doi: 10.1021/jm950644v. J Med Chem. 1996. PMID: 8558530

9

Effects of besipirdine at the voltage-dependent sodium channel.

Tang L, Smith CP, Huger FP, Kongsamut S. Tang L, et al. Among authors: huger fp. Br J Pharmacol. 1995 Nov;116(5):2468-72. doi: 10.1111/j.1476-5381.1995.tb15097.x. Br J Pharmacol. 1995. PMID: 8581286 Free PMC article.

10

Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galanthamine.

Bores GM, Huger FP, Petko W, Mutlib AE, Camacho F, Rush DK, Selk DE, Wolf V, Kosley RW Jr, Davis L, Vargas HM. Bores GM, et al. Among authors: huger fp. J Pharmacol Exp Ther. 1996 May;277(2):728-38. J Pharmacol Exp Ther. 1996. PMID: 8627552

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

16 results

Search Page

Filters